Cardiol Therapeutics

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRDL and other ETFs, options, and stocks.

About CRDL

Cardiol Therapeutics, Inc. is a clinical-stage life sciences company focused on developing anti-inflammatory therapies for cardiovascular disease (CVD). Their lead product, CardiolRx, is a pharmaceutical manufactured cannabidiol formulation being investigated in a Phase II/III study in hospitalized patients testing positive for COVID-19 with a prior history of, or risk factors for CVD.

CEO

David G. Elsley

CEODavid G. Elsley

Employees

Employees19

Headquarters

Oakville, Ontario

HeadquartersOakville, Ontario

Founded

2017

Founded2017

Employees

Employees19

CRDL Key Statistics

Market cap

68.14M

Market cap68.14M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

396.00K

Average volume396.00K

High today

$1.14

High today$1.14

Low today

$1.02

Low today$1.02

Open price

$1.13

Open price$1.13

Volume

377.61K

Volume377.61K

52 Week high

$4.96

52 Week high$4.96

52 Week low

$1.00

52 Week low$1.00

CRDL Earnings

-$0.18

-$0.12

-$0.06

$0.00

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Nov 14, After Hours

ActualExpected Nov 14, After Hours